Potential MRPS17 as A Cancer and Immune-related Drug/Biomarker

Target Name: MRPS17

NCBI ID: G51373

MRPS17

Potential MRPS17 as A Cancer and Immune-related Drug/Biomarker

MRPS17 (MRP-S17) is a protein that is expressed in various tissues throughout the body. It is a key regulator of the homeostasis of the cell, and is involved in the production of a variety of proteins that are essential for cell survival and growth. One of the most interesting aspects of MRPS17 is its potential as a drug target or biomarker.

The exact function of MRPS17 is not well understood, but it is known to play a role in the regulation of cell growth and differentiation. It is expressed in a variety of tissues, including the brain, heart, and kidneys, and has been shown to be involved in the development and maintenance of various diseases, including cancer.

One of the key reasons why MRPS17 is being targeted as a drug or biomarker is its role in the development of cancer. Studies have shown that high levels of MRPS17 are associated with the development of various types of cancer, including breast, ovarian, and prostate cancer. Additionally, MRPS17 has been shown to promote the growth and survival of cancer cells, which makes it an attractive target for cancer therapies.

Another potential mechanism by which MRPS17 may be targeted as a drug or biomarker is its role in the regulation of cellular processes that are important for human health. For example, MRPS17 has been shown to be involved in the production of extracellular matrix (ECM) proteins, which are important for maintaining tissue structure and function. Additionally, MRPS17 has been shown to regulate the production of proteins that are involved in cell signaling pathways, which can have a negative impact on human health if disrupted.

Another potential mechanism by which MRPS17 may be targeted as a drug or biomarker is its role in the regulation of cellular processes that are important for overall cellular health. For example, MRPS17 has been shown to be involved in the production of proteins that are involved in the immune response, which is important for maintaining cellular health and function. Additionally, MRPS17 has been shown to regulate the production of proteins that are involved in cell death and repair, which can help to maintain cellular health and function.

In conclusion, MRPS17 is an interesting protein that is being targeted as a drug or biomarker due to its potential role in the regulation of cellular processes that are important for human health. Further research is needed to fully understand the functions of MRPS17 and its potential as a drug or biomarker.

Protein Name: Mitochondrial Ribosomal Protein S17

The "MRPS17 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MRPS17 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets